YUANBIN CHEN M.D. PH.D. NPI 1467627653

NPI Details

Yuanbin Chen, M.D., PH.D. is a medical oncology internal medicine in Grand Rapids, MI with 27 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Yuanbin Chen, M.D., PH.D. NPI is 1467627653. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

145 MICHIGAN ST NE
SUITE 3100
GRAND RAPIDS, MI
ZIP 49503-562
Phone: (616) 954-9800
Fax: (616) 954-2116

The NPI 1467627653 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, azacitidine, 1 mg (HCPCS:J9025)
• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, pemetrexed, not otherwise specified, 10 mg (HCPCS:J9305)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, durvalumab, 10 mg (HCPCS:J9173)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Injection, etoposide, 10 mg (HCPCS:J9181)
• Injection, rituximab-arrx, biosimilar, (riabni), 10 mg (HCPCS:Q5123)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, cisplatin, powder or solution, 10 mg (HCPCS:J9060)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
• Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
• Adrenocorticotropic hormone (acth) level (HCPCS:82024)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Magnesium level (HCPCS:83735)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Unclassified drugs (HCPCS:J3490)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
• Hepatitis b core antibody measurement (HCPCS:86704)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Injection of drug or substance into vein (HCPCS:96374)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Blood test, clotting time (HCPCS:85610)
• Ferritin (blood protein) level (HCPCS:82728)
• Hepatitis b surface antibody measurement (HCPCS:86706)
• Hepatitis c antibody measurement (HCPCS:86803)
• Measurement of hepatitis a antibody (HCPCS:86708)
• Administration of prolonged chemotherapy into vein (HCPCS:96416)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Iron level (HCPCS:83540)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Hospital discharge day management, more than 30 minutes (HCPCS:99239)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)

The enumeration date for this NPI number is 4/28/2008 and was last updated on 2/15/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: